FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00Faron Pharmaceuticals: Faron Pharmaceuticals Ltd: Director Dealing
AnnouncementFaron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
AnnouncementFaron Pharmaceuticals: Faron Pharmaceuticals Ltd: Director Dealing
AnnouncementFaron Pharmaceuticals: Faron Pharmaceuticals Ltd: Director Dealing
AnnouncementFaron Pharmaceuticals: Faron Pharmaceuticals Ltd: Director Dealing
AnnouncementREG - AIM - AIM Notice - 17/03/2026
AnnouncementFaron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
AnnouncementFaron Pharmaceuticals: The Finnish Financial Supervisory Authority has approved Faron's rights offering prospectus
AnnouncementFaron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
AnnouncementFaron Pharmaceuticals: Inside Information: Faron publishes the terms and conditions of a fully covered rights offering of approximately EUR 40 million and updates cash runway
AnnouncementFaron Pharmaceuticals: Update to Faron’s Financial Calendar and date of the Annual General Meeting in 2026
AnnouncementFaron Pharmaceuticals: Correction: Faron Pharmaceuticals Ltd’s Annual Report 2025 published
AnnouncementFaron Pharmaceuticals: Faron Pharmaceuticals Ltd’s Annual Report 2025 published
AnnouncementFaron Pharmaceuticals: Faron’s Financial Statements Release 1 January to 31 December 2025
AnnouncementFaron Pharmaceuticals: Faron Pharmaceuticals Ltd: Results of the Extraordinary General Meeting
AnnouncementFaron Pharmaceuticals: Inside Information: Faron Pharmaceuticals Ltd is planning a rights offering of approximately EUR 40 million to strengthen its capital structure and to drive lead asset bexmarilimab to key milestones
AnnouncementFaron Pharmaceuticals: Faron Pharmaceuticals Ltd: NOTICE TO THE EXTRAORDINARY GENERAL MEETING
AnnouncementREG - AIM - AIM Notice - 05/02/2026
AnnouncementFaron Pharmaceuticals: Faron Pharmaceuticals Ltd: Registration of New Shares
Announcement